Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pulmonary surfactant is a complex mixture of lipids and proteins that lines the alveoli of the lungs. It reduces surface tension, prevents alveolar collapse, and facilitates gas exchange. It also plays a role in host defense and immune modulation. Deficiency or dysfunction of pulmonary surfactant is implicated in various lung diseases, including neonatal RDS and ARDS. Surfactant replacement therapy is used to treat neonatal RDS.
Reduction of alveolar surface tension
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pulmonary Surfactant (PS).